LexDanaLexDanabeta
Inventor

Jean-Christophe Carry

Inventor
Saint Maur des Fosses, FR

Overview

45→
Patents
1999–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 45 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes22%
C07KPeptides4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
PatentTitleYear
10,980,816Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof202110,736,904Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof202010,500,212Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof201910,220,044Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof20199,744,176'Therapeutic uses of novel thienopyrimidine derivatives'20179,221,828'N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticals'20159,221,817'Anti-cancer compound and pharmaceutical composition containing the same'20159,133,168'Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors'20159,115,140'Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof'20159,073,917'Anti-cancer compound and pharmaceutical composition containing the same'20158,993,565'(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors'20158,791,255'(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors'20148,163,768'1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them'20127,884,123'Substituted thieno[2,3-c]pyrazoles, process for preparing them, compositions containing them, and use thereof'20117,772,261'Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapeutic application thereof'20107,638,521'3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them'20097,595,320'Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, process for preparing them, compositions containing them and use thereof'20097,589,117'Isoindolone derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them'20097,531,663'3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them'20097,473,701'Substituted indazoles, compositions containing them, method of production and use'20097,230,007'Derivatives of 3-(Guanidinocarbonyl) heterocycle, methods of preparation and intermediates thereof, their use as medicaments, and pharmaceutical compositions therefrom'20077,227,022'Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase'20077,078,414'Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them'20067,078,428'Isoindolone derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them'20066,953,796'Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase'20056,903,217'Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them'20056,872,740'Use of 2-amino-4-heteroarylethyl-thiazoline derivatives as inhibitors of inducible no-synthase'20056,858,638'Substituted indazoles, compositions containing them, method of production and use'20056,762,196'Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase'20046,699,895'2-aminothiazoline derivatives and process for preparing the same'20046,699,867'Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase'20046,603,005'Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them'20036,451,821'Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase'20026,420,566'Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof'20026,407,110'Polyhydroxyalkylpyrazine derivatives and their preparation and medicines containing them'20026,403,610'Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them'20026,399,613'Pyrazine derivatives, their preparation and medicaments containing them'20026,392,042'Polyhydroxyalkylpyrazine derivatives, their preparation and medicaments comprising them'20026,362,185'Polyhydroxyalkylpyrazine derivatives, their preparation and the medicaments comprising them'20026,288,066'Polyhydroxybutylpyrazines, their preparation and medicaments comprising them'20016,207,675'Pyrrole derivatives, their preparation and pharmaceutical compositions containing them'20015,994,299'Cyclosporin compounds, their preparation and the pharmaceutical compositions which contain them'19995,977,067'Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them'19995,965,527'Cyclosporin compounds, their preparation and the pharmaceutical compositions which contain them'19995,948,755'Cyclosporin compound, its preparation and the pharmaceutical compositions which contain it'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2001Patents assigned to RHONE POULENC RORER SA (5)· patent assignee history
1999–2002Based in Meudon, FR· patent location history
2001–2012Patents assigned to AVENTIS PHARMA SA (21)· patent assignee history
2002–2015Based in Saint Maur des Fosses, FR· patent location history
2002–2011Based in Saint Maur, FR· patent location history
2006–2009Patents assigned to SANOFI AVENTIS DEUTSCHLAND (6)· patent assignee history
2010–2021Based in Paris, FR· patent location history
2012–2015Patents assigned to CARRY JEAN-CHRISTOPHE (4)· patent assignee history
2014–2021Patents assigned to SANOFI SA (12)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AVENTIS PHARMA SA212001–2012
SANOFI SA122014–2021
SANOFI AVENTIS DEUTSCHLAND62006–2009
RHONE POULENC RORER SA51999–2001
CARRY JEAN-CHRISTOPHEself42012–2015
Locations
LocationPatentsSpan
Saint Maur des Fosses, FR192002–2015
Paris, FR122010–2021
Meudon, FR91999–2002
Saint Maur, FR52002–2011